Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT05096663 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

NETWORK

Sponsor class

Conditions

Advanced Lung Non-Small Cell Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8

Interventions

DIETARY_SUPPLEMENT: Cobalamin
DRUG: Dexamethasone
DRUG: Docetaxel
DIETARY_SUPPLEMENT: Folic Acid
DRUG: Gemcitabine
DRUG: Nogapendekin Alfa
BIOLOGICAL: Pembrolizumab
DRUG: Pemetrexed
BIOLOGICAL: Ramucirumab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]